%D9%83%D8%A8%D8%AF_%D8%AF%D9%87%D9%86%D9%8AEsteatosi_hep%C3%A0tica%D8%AC%DB%95%D8%B1%DA%AF%DB%8C_%DA%86%DB%95%D9%88%D8%B1Category:Fatty_liverSteat%C3%B3za_jaterFettleberFatty_liver_diseaseEsteatosis_hep%C3%A1tica%DA%A9%D8%A8%D8%AF_%DA%86%D8%B1%D8%A8RasvamaksaSt%C3%A9atose_h%C3%A9patique%D7%9E%D7%97%D7%9C%D7%AA_%D7%94%D7%9B%D7%91%D7%93_%D7%94%D7%A9%D7%95%D7%9E%D7%A0%D7%99Steatosi_epatica%E8%84%82%E8%82%AA%E8%82%9D%EC%A7%80%EB%B0%A9%EA%B0%84Kepen%C5%B3_surieb%C4%97jimas%E1%80%82%E1%80%BC%E1%80%AD%E1%80%AF%E1%80%9F%E1%80%BA%E1%80%92%E1%80%B8%E1%80%92%E1%80%AF%E1%81%9A%E1%80%BA%E1%80%93%E1%80%9C%E1%80%AE%E1%80%AF%E1%80%80%E1%81%A0%E1%80%B1%E1%81%9A%E1%80%BALeververvetting%E0%A8%9A%E0%A8%B0%E0%A8%AC%E0%A9%80_%E0%A8%9C%E0%A8%BF%E0%A8%97%E0%A8%B0_%E0%A8%A6%E0%A9%80_%E0%A8%AC%E0%A8%BF%E0%A8%AE%E0%A8%BE%E0%A8%B0%E0%A9%80F%C3%ADgado_gorduroso%D0%A1%D1%82%D0%B5%D0%B0%D1%82%D0%BE%D0%B7_%D0%BF%D0%B5%D1%87%D0%B5%D0%BD%D0%B8FettleverMafuta_ya_ini%E0%AE%95%E0%AF%8A%E0%AE%B4%E0%AF%81%E0%AE%AA%E0%AF%8D%E0%AE%AA%E0%AF%81%E0%AE%AE%E0%AE%BF%E0%AE%95%E0%AF%81_%E0%AE%88%E0%AE%B0%E0%AE%B2%E0%AF%8DKaraci%C4%9Fer_ya%C4%9Flanmas%C4%B1Gan_nhi%E1%BB%85m_m%E1%BB%A1Q6058862%E8%84%82%E8%82%AA%E8%82%9D
about
P1050
P1542
P509
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individualsRole of Transcription Factors in Steatohepatitis and Hypertension after Ethanol: The Epicenter of MetabolismGenetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and SteatohepatitisDrug Induced Steatohepatitis: An Uncommon Culprit of a Common DiseaseDoes Diacylglycerol Accumulation in Fatty Liver Disease Cause Hepatic Insulin Resistance?Melatonin: a potential intervention for hepatic steatosisThe therapy of insulin resistance in other diseases besides type 2 diabetesThe role of ursodeoxycholic acid in non-alcoholic steatohepatitis: a systematic reviewLessons from mouse models of high-fat diet-induced NAFLDDevelopment of nonalcoholic hepatopathy: contributions of oxidative stress and advanced glycation end productsDiagnosis and management of non-alcoholic fatty liver disease and related metabolic disorders: consensus statement from the Study Group of Liver and Metabolism, Chinese Society of EndocrinologyMultiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH)The role of endocannabinoids system in fatty liver disease and therapeutic potentialsPreoperative Methods to Reduce Liver Volume in Bariatric Surgery: a Systematic ReviewTherapeutic options in pediatric non alcoholic fatty liver disease: current status and future directionsSystematic review on the treatment of pentoxifylline in patients with non-alcoholic fatty liver diseaseFatty liver diseases, bile acids, and FXRIron and non-alcoholic fatty liver diseaseHepatic steatosis and fibrosis: Non-invasive assessment.Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directionsEnvironmental pollution: a tangible risk for NAFLD pathogenesisSystematic review and meta-analysis on the adverse events of rimonabant treatment: considerations for its potential use in hepatology.Nutrigenomics therapy of hepatisis C virus induced-hepatosteatosis.Pathogenesis of non-alcoholic fatty liver disease.Viewpoints on the way to a consensus session: where does insulin resistance start? The liver.Inflammatory mediators of hepatic steatosis.The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD).Steatosis and steatohepatitis: complex disorders.Energy and fructose from beverages sweetened with sugar or high-fructose corn syrup pose a health risk for some peoplePediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets.Nonalcoholic fatty liver disease: molecular pathways and therapeutic strategiesSystematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.Role of transcription factor modifications in the pathogenesis of insulin resistance.Diagnosis and evaluation of nonalcoholic fatty liver disease.The role of metformin in the management of NAFLDHepatic growth hormone and glucocorticoid receptor signaling in body growth, steatosis and metabolic liver cancer development.Clinical review of nonalcoholic steatohepatitis in liver surgery and transplantationThe relationship between nonalcoholic fatty liver disease and colorectal cancer: the future challenges and outcomes of the metabolic syndrome.Nonalcoholic fatty liver disease and cardiovascular disease: has the time come for cardiologists to be hepatologists?Bariatric surgery as potential treatment for nonalcoholic fatty liver disease: a future treatment by choice or by chance?
P921
description
Krankheit
@de
higado graso
@es
kehon rasvan kertyminen maksaan
@fi
lipid storage disease characte ...... s via the process of steatosis
@en
lipidlagringsforstyrring
@nn
lésion du foie correspondant à la surcharge de graisse dans le cytoplasme des hépatocytes
@fr
malattia epatica
@it
onemocnění
@cs
sykdom som innebærer opphopning av fett i levercellene
@nb
name
Esteatosis hepática
@es
Fettleber
@de
Gan nhiễm mỡ
@vi
Karaciğer yağlanması
@tr
Kepenų suriebėjimas
@lt
Leververvetting
@nl
Mafuta ya ini
@sw
Rasvamaksa
@fi
Steatóza jater
@cs
esteatosi hepàtica
@ca
type
label
Esteatosis hepática
@es
Fettleber
@de
Gan nhiễm mỡ
@vi
Karaciğer yağlanması
@tr
Kepenų suriebėjimas
@lt
Leververvetting
@nl
Mafuta ya ini
@sw
Rasvamaksa
@fi
Steatóza jater
@cs
esteatosi hepàtica
@ca
altLabel
Esteatosis hepatica
@es
Fatty liver disease
@en
alkoholisk feittlever
@nn
fatty change of liver
@en
fatty degeneration of the liver
@en
fatty liver
@en
fegato grasso
@it
feittlever
@nn
hepatic lipidosis
@en
hepatic steatosis
@en
prefLabel
Esteatosis hepática
@es
Fettleber
@de
Gan nhiễm mỡ
@vi
Karaciğer yağlanması
@tr
Kepenų suriebėjimas
@lt
Leververvetting
@nl
Mafuta ya ini
@sw
Rasvamaksa
@fi
Steatóza jater
@cs
esteatosi hepàtica
@ca
P2293
P227
P486
P508
P6366
P646
P672
P1245
P1417
science/fatty-liver-disease
P1692
P1748
P1995
P227
P2892
P31
P3417
Fatty-Liver
Fatty-Liver-Disease